Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Tetraphase Pharmaceuticals, Inc.

Home Clinical Trial Sponsors and OrganizationsTetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

ACTIVE

930 Winter St Ste 1500, 马萨诸塞州米德尔塞克斯县, Massachusetts, United Statestphase.comPublic67 employeesEstablished: 2006-01-01

Also known as:

tetraphase pharmaceuticals

Part of La Jolla Pharmaceutical Co.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

45

29 active

Approvals

2

Total approvals

Agencies

1

Regulatory bodies

Founded

2006

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

26

57.8%

Phase 3

4

8.9%

Phase 2

1

2.2%

Trial Status Distribution

Active, not recruiting

29

64.4%

Completed

16

35.6%

Clinical Trials

Trials sponsored by this organization (45)

A Safety and PK Study of IV Eravacycline

Dec 201819 participants

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers

Nov 20188 participants

A Phase 1 TP-271 Oral PK Multiple Ascending Dose Study

Mar 201840 participants

A Phase 1 Safety and PK Study of IV TP-271

Aug 201740 participants

A Phase 1 TP-271 Oral PK Single Ascending Dose Study

Mar 201756 participants

Multicenter Study to Assess the Efficacy and Safety of Eravacycline Compared with Ertapenem in Complicated Urinary Tract Infections

Active, not recruiting

Jan 20171,200 participants

Multicenter Study to Assess the Efficacy and Safety of Eravacycline Compared with Ertapenem in Complicated Urinary Tract Infections

Active, not recruiting

Jan 20171,200 participants

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections

Jan 20171,205 participants

Page 1 of 6

Approvals

Approvals by Agency

FDA

Food and Drug Administration

2

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials45
Approvals2
News

Back to Organizations